絞り込み

16645

広告

Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness.

著者 Thomas RK , Baker G , Lind J , Dursun S
J Psychopharmacol.2018 Sep 05 ; ():269881118793104.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (9view , 0users)

Full Text Sources

Medical

Miscellaneous

Intravenous ketamine has been established as an efficacious and safe treatment, with transient effect, for treatment-resistant depression. However, the effectiveness of intravenous ketamine in non-research settings and with ultraresistant depression patients remains understudied.
PMID: 30182797 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード